Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Moderna, Inc.    MRNA

MODERNA, INC.

(MRNA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
05/20/2020 05/21/2020 05/22/2020 05/26/2020 05/27/2020 Date
73.47(c) 67(c) 69(c) 57.71(c) 52.18(c) Last
53 655 278 35 317 971 28 912 678 40 332 555 59 053 199 Volume
+2.51% -8.81% +2.99% -16.36% -9.58% Change
More quotes
Financials (USD)
Sales 2020 97,1 M - -
Net income 2020 -516 M - -
Net cash position 2020 1 752 M - -
P/E ratio 2020 -36,7x
Yield 2020 -
Sales 2021 844 M - -
Net income 2021 -387 M - -
Net cash position 2021 2 483 M - -
P/E ratio 2021 -50,3x
Yield 2021 -
Capitalization 20 289 M 20 289 M -
EV / Sales 2020 191x
EV / Sales 2021 21,1x
Nbr of Employees 850
Free-Float 79,7%
More Financials
Company
Moderna, Inc. is engaged in transformative medicines based on messenger ribonucleic acid (mRNA). It has created a platform to improve the underlying pharmaceutical properties of our mRNA medicines. Its platform consists of three areas: mRNA technologies, delivery technologies, and manufacturing processes. It is pursuing mRNA science to minimize the undesirable activation of the immune system by mRNA and to maximize... 
More about the company
Surperformance© ratings of Moderna, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on MODERNA, INC.
04:03pModerna rally loses steam over COVID-19 vaccine worries
RE
08:10aMODERNA : to Present at Upcoming Investor Conferences
BU
07:26aGeopolitical Power Play Over Coronavirus Vaccine Leaves Drugmakers in the Mid..
DJ
05/26MODERNA ALERT : Bragar Eagel & Squire, P.C. is Investigating Moderna, Inc. on Be..
BU
05/26Merck to buy Austrian vaccine maker as it jumps into COVID-19 race
RE
05/26MODERNA : to Host Virtual Science Day on June 2, 2020
BU
05/23HOME DEPOT, MODERNA, WALMART : Stocks That Defined the Week -- WSJ
DJ
05/22HOME DEPOT, MODERNA, WALMART : Stocks That Defined the Week
DJ
05/21Correction to the Drug Pricing Article
DJ
05/21Law Offices of Howard G. Smith Announces Investigation of Moderna, Inc. (MRNA..
BU
05/21U.S. to Invest $1.2 Billion to Secure Potential Coronavirus Vaccine From Astr..
DJ
05/21Coronavirus Revives Debate Over Drug Pricing
DJ
05/21U.S. to Invest $1.2 Billion to Secure Potential Coronavirus Vaccine From Astr..
DJ
05/20MODERNA, INC. : Entry into a Material Definitive Agreement, Other Events, Financ..
AQ
05/20ONGOING INVESTIGATION ALERT : The Schall Law Firm Announces it is Investigating ..
BU
More news
News in other languages on MODERNA, INC.
05/22Les USA lancent un plan massif de test des vaccins expérimentaux contre le co..
05/22Les USA lancent un plan massif de test des vaccins expérimentaux contre le co..
05/22WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
05/20Wall Street devrait repartir de l'avant, l'Europe hésite
05/19Wall Street refroidie par les doutes sur le possible vaccin de Moderna
More news
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 85,42 $
Last Close Price 52,18 $
Spread / Highest target 115%
Spread / Average Target 63,7%
Spread / Lowest Target -0,34%
EPS Revisions
Managers
NameTitle
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
Noubar B. Afeyan Chairman
Lorence H. Kim Chief Financial Officer
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capitalization (M$)
MODERNA, INC.195.04%22 439
LONZA GROUP37.54%37 323
IQVIA HOLDINGS INC.-7.13%27 403
SEATTLE GENETICS, INC.32.76%26 258
CELLTRION, INC.17.68%23 280
INCYTE CORPORATION13.80%21 450